CDA and neoplasm: In this study, we screened the Institut Curie-CNRS chemical library and identified X55, a naphthol derivative, which targeted 40% of CDA-deficient tumor cell lines and 22% of CDA-proficient tumor cell lines, and had no effect on the growth of non-tumoral cells, regardless of their CDA expression status.